Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study

  1. Berger, S.P.
  2. Sommerer, C.
  3. Witzke, O.
  4. Tedesco, H.
  5. Chadban, S.
  6. Mulgaonkar, S.
  7. Qazi, Y.
  8. de Fijter, J.W.
  9. Oppenheimer, F.
  10. Cruzado, J.M.
  11. Watarai, Y.
  12. Massari, P.
  13. Legendre, C.
  14. Citterio, F.
  15. Henry, M.
  16. Srinivas, T.R.
  17. Vincenti, F.
  18. Gutierrez, M.P.H.
  19. Marti, A.M.
  20. Bernhardt, P.
  21. Pascual, J.
Aldizkaria:
American Journal of Transplantation

ISSN: 1600-6143,  1600-6135

Argitalpen urtea: 2019

Alea: 19

Zenbakia: 11

Orrialdeak: 3018-3034

Mota: Artikulua

DOI: 10.1111/AJT.15480 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus